[HTML][HTML] Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
MZ Zhurinov, AF Miftakhova, V Keyer, ZT Shulgau… - Molecules, 2023 - mdpi.com
In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked.
MZ Zhurinov, AF Miftakhova, V Keyer… - Molecules (Basel …, 2023 - europepmc.org
In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
MZ Zhurinov, AF Miftakhova, V Keyer… - Molecules (Basel …, 2023 - pubmed.ncbi.nlm.nih.gov
In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
MZ Zhurinov, AF Miftakhova, V Keyer, ZT Shulgau… - …, 2023 - search.proquest.com
Abstract In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked.
MZ Zhurinov, AF Miftakhova, V Keyer… - …, 2023 - search.ebscohost.com
Abstract In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
Glycyrrhiza glabra L. extracts and other therapeutics against SARS-CoV-2 in Central Eurasia: available but overlooked.
MZ Zhurinov, AF Miftakhova, V Keyer, ZT Shulgau… - 2023 - cabidigitallibrary.org
Abstract In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
[HTML][HTML] Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
MZ Zhurinov, AF Miftakhova, V Keyer, ZT Shulgau… - Molecules, 2023 - ncbi.nlm.nih.gov
Abstract In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
virus and have proven clinical efficacy is still limited. The aim of this study was to evaluate …
[引用][C] Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked
MZ Zhurinov, AF Miftakhova, V Keyer, ZT Shulgau… - Molecules, 2023 - europepmc.org
In Central Eurasia, the availability of drugs that are inhibitors of the SARS-CoV-2 virus and
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …
have proven clinical efficacy is still limited. The aim of this study was to evaluate the activity …